PHARMA
PHARMAPharmaceutical Hydrogenation Membrane in Canada
Catalytic hydrogenation is a critical step in active pharmaceutical ingredient (API) synthesis. Canada's Hydrogen Strategy positions the country as a major hydrogen producer and exporter.
Market Context
CanadaPolicy
H₂ Target
Cities
Industries
Ultra-Clean Hydrogen Source
Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.
GMP-Compatible On-Site Generation
On-site electrolysis provides a controlled, traceable hydrogen source that simplifies GMP documentation and qualification versus multi-sourced delivered gas.
Batch-Flexible Operation
Pharmaceutical manufacturing operates in batches. IONZERA's high wettability supports start-stop operation, generating hydrogen only when hydrogenation reactors require it.
Pharmaceutical Hydrogenation in Canada’s Hydrogen Market
Canada's Hydrogen Strategy positions the country as a major hydrogen producer and exporter. Alberta's oil and gas expertise is pivoting toward clean hydrogen, while British Columbia leverages hydropower for green electrolysis. Calgary and Edmonton are emerging as hydrogen technology and deployment hubs.
IONZERA supports Canadian hydrogen ambitions with a high-performance membrane that improves electrolysis efficiency, helping Canadian projects compete in the global clean hydrogen market.
Lower Resistance
Thinner Profile
PERFORMANCE ADVANTAGE
Why IONZERA for Pharmaceutical Hydrogenation in Canada
Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.
Shipping & Logistics
Air freight from India to Calgary/Vancouver in 6-8 business days.
Area Resistance
3x LOWERThickness
20% THINNERFrequently Asked Questions
Why choose IONZERA for pharmaceutical hydrogenation in Canada?
IONZERA delivers 3x lower ionic resistance than Zirfon, making it ideal for pharmaceutical hydrogenation applications in Canada. IONZERA supports Canadian hydrogen ambitions with a high-performance membrane that improves electrolysis efficiency, helping Canadian projects compete in the global clean hydrogen market.
How does IONZERA fit Canada's hydrogen strategy?
IONZERA's high-efficiency membrane supports both Alberta's blue-to-green hydrogen transition and BC's hydropower-based green electrolysis by reducing per-kg production costs through lower membrane resistance.
EXPLORE MORE
Request Pharmaceutical Hydrogenation Samples for Canada
Contact G-Hexa for IONZERA pharmaceutical hydrogenation membrane samples, technical specifications, and volume pricing for Canada-based projects.
Request Sample